Edwards Lifesciences Corporation
EW.SW News Today: Stay Updated with the Latest Edwards Lifesciences Corporation News in Real Time
Find EW.SW news now at Meyka AI. Stay informed with the latest Edwards Lifesciences Corporation stocks updates, including price news, market analysis, and expert insights.
DOV Earnings Preview: Dover Q1 2026 on April 23
Dover Corporation (DOV) reports Q1 2026 earnings April 23. Analysts expect $2.27 EPS and $2.00B revenue. Meyka AI rates DOV B+.
FSV.TO FirstService Earnings Preview April 23, 2026
FirstService Corporation (FSV.TO) reports Q1 2026 earnings April 23. Analysts expect $1.21 EPS and $1.79B revenue.
DNZOF DENSO Earnings Preview April 23, 2026
DENSO earnings preview: Analysts expect $0.3529 EPS and $11.62B revenue on April 23. Stock rated B by Meyka AI.
AXR: AMREP 10% Owner Dahl Buys 1,519 Shares April 22, 2026
AMREP insider James Dahl acquired 1,519 shares at $27.25 on April 20, 2026. Major shareholder buying signals confidence in AXR stock.
PCG Stock Earnings Preview: PG&E Reports Q2 2026 Results April 23
PG&E (PCG) earnings preview for April 23, 2026. Analysts expect $0.38 EPS and $6.34B revenue. Historical performance analysis inside.
6857.T stock gains 2.95% as Advantest joins Applied Materials EPIC platform
Advantest (6857.T) rises 2.95% on JPX after announcing strategic partnership with Applied Materials. Market cap reaches 19.75T JPY.
EW Edwards Lifesciences Earnings Preview April 23
Edwards Lifesciences earnings preview: EPS estimate $0.72, revenue $1.60B. Analyst consensus, historical performance, and key metrics to watch.
BSX Stock April 22: Class Action Deadline Alert for Investors
Boston Scientific (BSX) class action lawsuit with April 22 deadline. Investors in BSX, EOSE, SLNO, NKTR must act now. Learn your legal rights.
TLN Overweight Rating Maintained by Morgan Stanley April 2026
Morgan Stanley maintains Overweight rating on TLN, raising price target to $479 from $472 on April 21, 2026.